MIF inhibitor (MRC Technology/Proximagen)

N/A

Report date: 2024/12/05 15:16:11
NME

Base Information

Drug NameMIF inhibitor (MRC Technology/Proximagen)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMacrophage migration inhibitory factor inhibitors
TargetsMacrophage migration inhibitory factor
Therapy Area/IndicationsInflammationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesProximagen Group plc
China Registration ClassN/A

Develop Information

Active CompaniesProximagen Group plc
Inactive CompaniesN/A
Active IndicationsInflammationAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A